Cargando…
Efficacy and safety of dronedarone across age and sex subgroups: a post hoc analysis of the ATHENA study among patients with non-permanent atrial fibrillation/flutter
AIMS: Age and sex may impact the efficacy of antiarrhythmic drugs on cardiovascular outcomes and arrhythmia recurrences in patients with atrial fibrillation (AF). We report on a post hoc analysis of the ATHENA study (NCT00174785), which examined cardiovascular outcomes in patients with non-permanent...
Autores principales: | Curtis, Anne B, Zeitler, Emily P, Malik, Aysha, Bogard, Andrew, Bhattacharyya, Nidhi, Stewart, John, Hohnloser, Stefan H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681127/ https://www.ncbi.nlm.nih.gov/pubmed/34374766 http://dx.doi.org/10.1093/europace/euab208 |
Ejemplares similares
-
Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial
por: Vamos, Mate, et al.
Publicado: (2021) -
Correction to: Efficacy and safety of dronedarone across age and sex subgroups: a post hoc analysis of the ATHENA study among patients with non-permanent atrial fibrillation/flutter
Publicado: (2023) -
Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study
por: Vamos, Mate, et al.
Publicado: (2019) -
Effect of dronedarone vs. placebo on atrial fibrillation progression: a post hoc analysis from ATHENA trial
por: Blomström-Lundqvist, Carina, et al.
Publicado: (2023) -
Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study
por: Blomström‐Lundqvist, Carina, et al.
Publicado: (2020)